Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the study is to provide a road map that can help organizational leaders understand how to sequence their financial and human capital investments related to bundled payment arrangements. Although specific strategies will vary between organizations, providing evidence from a health system with extension experience bundling care for orthopedic joint replacements can be instructive for other providers entering new building arrangements. Insights from the experience of the health system can help other organizations prioritize effort and focus energy around strategies that increase the likelihood of succeeding under Comprehensive Care for Joint Replacement (CJR) and other bundled payment contracts.
This study will analyze data from a health system with the longest standing experience with bundled payments for orthopedic procedures. The goal of this work is to provide insights from this health system's six years of experience and offer a road map that other organizations around the country can use as they plan and implement their own bundled payment programs. The investigators will conduct a retrospective analysis on quality and cost data from a health system with extensive experience with bundled payments for orthopedic joint replacements. The study design will consist of three parts: first, the team will report trends in quality and cost outcomes over time using descriptive statistics; second, the team will perform multi-variable regression analyses on the data to identify significant predictors of different quality and cost outcomes and provide statistical tests on the trends; third, the team will evaluate changes in physician and hospital level variation along the outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Surgical site infection at the physician level | The study team will evaluate at the physician level. The quality metric evaluated will be average rate of surgical site infections. | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Cost of care during hospitalization | The study team will measure secondary cost outcome variables on the episode level. The cost metric to be evaluated is per episode costs of care during the hospitalization in which the surgery occurred. | 12 months |
| Cost of care post-discharge |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Orthopedic surgeons from one health system who participated over a five year span in bundled payment arrangements
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
The study team will measure secondary cost outcome variables on the episode level. The cost metric to be evaluated is per episode costs of care post-discharge. |
| 12 months |
| All-cause readmission rate at the physician level | The study team will evaluate at the physician level. The quality metric measured will be all-cause readmission rate. | 12 months |
| Venous thromboembolism at the physician level | The study team will evaluate at the physician level. The quality metric measured will be the rate of venous thromboembolism per physician in each quarter of analysis. | 12 months |
| Cost of care at the physician level | The study team will evaluate at the physician level. The cost metric evaluated will be the average costs of care during hospitalization in which the surgery occurred. | 12 months |
| Spending at the physician level | The study team will evaluate at the physician level. The cost metric evaluated will be average spending on care in combined hospitalization and post-discharge periods per physician in each quarter of analysis. | 12 months |